Extended RASmutations andanti-EGFR monoclonalantibody survivalbenefit in metastaticcolorectal cancer: ameta-analysis ofrandomized,controlled trials Michael J. SorichMichael D. WieseAndrew Rowland2014 год

Extended RAS mutations and anti-EGFR monoclonal antibody survival benefit in metastatic colorectal cancer: a meta-analysis of randomized, controlled trials
review